United Kingdom· GB-APID-40104011000001107
Ryeqo 40mg/1mg/0.5mg tablets
A medicinal product containing relugolix + estradiol + norethisterone acetate, registered in United Kingdom by Gedeon Richter (UK) Ltd.
Checked against NHS dm+d (United Kingdom) on
Informational only — not a medical device.
The record
At a glance
NHS dm+d (United Kingdom)- Active substance
- Relugolix + Estradiol + Norethisterone acetate
- Manufacturer
- Gedeon Richter (UK) Ltd
- Country
- United Kingdom (GB)
- ATC code
- —
- Reimbursed
- Not published by this register
- Source register
- NHS dm+d (United Kingdom)
- Last checked
- September 13, 2026
Packs & prices · 2
- gtin5997001328200
- gtin5997001371770
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Same medicine, other countries
Relugolix + estradiol + norethisterone acetate in 7 other countries
What each register calls a product with the same active substance — salts and hydrates count as the same.
- SwitzerlandRyeqo, FilmtablettenGedeon Richter (Schweiz) AG
- NorwayRyeqoOrifarm AS
- CanadaMYFEMBREESUMITOMO PHARMA SWITZERLAND GMBH
- PolandRyeqoGedeon Richter Plc.
- SwedenRyeqo 40 mg/1 mg/0,5 mg Filmdragerad tablettGedeon Richter Plc
- NetherlandsRyeqo 40 mg/1 mg/0.5 mg, filmomhulde tablettenGedeon Richter Plc
- SpainRYEQO 40 MG/1 MG/0,5 MG COMPRIMIDOS RECUBIERTOS CON PELICULAGedeon Richter Plc.
Authorised across Europe · EMA
The same active substance is authorised in 3 EEA countries. Names it is sold under:
- Iceland · Ryeqo
- Liechtenstein · Ryeqo
- Norway · Ryeqo
Source: European Medicines Agency, Article 57 product data.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of NHS dm+d (United Kingdom). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/d323dc79-55da-40a9-97e3-918c3c2bcebd GET /v1/drugs/d323dc79-55da-40a9-97e3-918c3c2bcebd?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"apid": "40104011000001107",
"desc": "Ryeqo 40mg/1mg/0.5mg tablets (Gedeon Richter (UK) Ltd)",
"form": "Oral tablet",
"vpid": "40110411000001106",
"source": "dmd",
"vtm_id": "40104711000001109",
"strength": "500 microgram",
"substance": "Relugolix + Estradiol + Norethisterone acetate",
"ingredient": "Norethisterone acetate",
"supplier_code": "20177411000001101"
}See everything about relugolix + estradiol + norethisterone acetate.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.